InBios International, Inc. Email Format

Biotechnology ResearchWashington, United States51-200 Employees

InBios International, Inc. operates in the biotechnology research sector, focusing on the design, development, and manufacture of diagnostic assays for emerging infectious diseases and biothreats. Based in Seattle, Washington, the company lists its address as 307 Westlake Avenue North Suite 300 and employs 51 to 200 people. The firm maintains GMP compliance and regulatory approvals, being FDA registered, USDA licensed, and ISO 13485:2016 certified. Its product portfolio emphasizes accuracy, ease of use, and cost effectiveness, and it has participated in collaborations and contracts for diagnostic test development, including efforts related to COVID-19 that involved an Emergency Use Authorization for a SARS-CoV-2 rRT-PCR kit. Recent activity includes developing a Lyme diagnostic test (as of 2025) and launching an in vitro serological ELISA kit for presumptive clinical laboratory diagnosis of Strongyloides infection, capable of delivering results in under 75 minutes.

Sign up for free to view info

Company overview Employee directory